Cytori Therapeutics Inc (CYTX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Cytori Therapeutics Inc (CYTX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7261
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cytori Therapeutics Inc (Cytori) is a clinical stage cell therapy company. It develops cell therapies from autologous adipose-derived regenerative cells (ADRCs) for the treatment of cardiovascular disease, orthopedic conditions and gastrointestinal disorders. The company has two therapeutic development platforms, namely, Cytori Cell Therapy (CCT) and Cytori Nanomedicine. Cytori uses CCT platform works by enhancing blood flow, regulating the immune system, and facilitating wound repair. The Cytori Nanomedicine is a versatile and novel protein-stabilized liposomal nanoparticle technology used for drug encapsulation. The company offers its products to physicians, researchers, hospitals, clinics and other customers for commercial and research purposes. Cytori is headquartered in San Diego, California, the US.

Cytori Therapeutics Inc (CYTX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cytori Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cytori Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cytori Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cytori Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Cytori Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cytori Therapeutics Inc, Medical Equipment, Deal Details 10
Lorem Vascular Amends Licensing Agreement with Cytori Therapeutics 10
Cytori Therapeutics Enters Into Licensing Agreement With Bimini Technologies For Celution 11
Equity Offering 12
Cytori Therapeutics to Raise USD11 Million in Rights Offering of Shares 12
Cytori Therapeutics Plans to Raise Funds through Public Offering of Shares 14
Cytori Therapeutics Raises USD20 Million in Private Placement of Shares 15
Cytori Therapeutics Raises USD2.5 Million in Second and Final Tranche of Private Placement of Units 16
Cytori Therapeutics Raises Funds in First Tranche of Private Placement of Units 18
Cytori Therapeutics Raises USD10 Million in Private Placement of Units 20
Cytori Therapeutics Completes Public Offering Of Shares For US$23 Million 22
Cytori Therapeutics Completes Private Placement Of Shares For US$18.2 Million 23
Asset Transactions 25
Bimini Technologies Acquires Puregraft Rights From Cytori Therapeutics For Up To USD15 Million 25
Acquisition 26
Cytori Therapeutics Acquires Remaining 50% Stake in Olympus-Cytori from Olympus 26
Cytori Therapeutics Inc – Key Competitors 27
Cytori Therapeutics Inc – Key Employees 28
Cytori Therapeutics Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Aug 14, 2018: Cytori reports Q2 2018 business and financial results 30
May 10, 2018: Cytori Reports Q1 2018 Business and Financial Results 31
Mar 08, 2018: Cytori Reports Fourth Quarter and Full Year 2017 Business and Financial Results 32
Nov 09, 2017: Cytori Reports Third Quarter 2017 Business and Financial Results 33
Aug 10, 2017: Cytori Reports Second Quarter 2017 Business and Financial Results 34
May 11, 2017: Cytori Reports First Quarter 2017 Business and Financial Results 35
Mar 23, 2017: Cytori Reports Fourth Quarter and Full Year 2016 Business and Financial Results 36
Corporate Communications 37
Apr 03, 2017: Cytori Appoints Gregg Lapointe to Board of Directors 37
Product News 38
Jun 01, 2017: Cytori to Introduce Next-Generation Celution® Technology 38
Other Significant Developments 39
Jun 08, 2017: Long Term Safety Data Published on Cytori Technology for Breast Reconstruction After Oncologic Surgery & Radiation Therapy 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Cytori Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Cytori Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Cytori Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cytori Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cytori Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cytori Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Cytori Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Lorem Vascular Amends Licensing Agreement with Cytori Therapeutics 10
Cytori Therapeutics Enters Into Licensing Agreement With Bimini Technologies For Celution 11
Cytori Therapeutics to Raise USD11 Million in Rights Offering of Shares 12
Cytori Therapeutics Plans to Raise Funds through Public Offering of Shares 14
Cytori Therapeutics Raises USD20 Million in Private Placement of Shares 15
Cytori Therapeutics Raises USD2.5 Million in Second and Final Tranche of Private Placement of Units 16
Cytori Therapeutics Raises Funds in First Tranche of Private Placement of Units 18
Cytori Therapeutics Raises USD10 Million in Private Placement of Units 20
Cytori Therapeutics Completes Public Offering Of Shares For US$23 Million 22
Cytori Therapeutics Completes Private Placement Of Shares For US$18.2 Million 23
Bimini Technologies Acquires Puregraft Rights From Cytori Therapeutics For Up To USD15 Million 25
Cytori Therapeutics Acquires Remaining 50% Stake in Olympus-Cytori from Olympus 26
Cytori Therapeutics Inc, Key Competitors 27
Cytori Therapeutics Inc, Key Employees 28
Cytori Therapeutics Inc, Other Locations 29
Cytori Therapeutics Inc, Subsidiaries 29

List of Figures
Cytori Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Cytori Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Cytori Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Cytori Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Cytori Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cytori Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Cytori Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cytori Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Cytori Therapeutics Inc (CYTX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vivendi S.A. (VIV):企業の財務・戦略的SWOT分析
    Vivendi S.A. (VIV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Anavex Life Sciences Corp (AVXL):企業の財務・戦略的SWOT分析
    Anavex Life Sciences Corp (AVXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Venator Materials PLC (VNTR):企業の財務・戦略的SWOT分析
    Venator Materials PLC (VNTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Cinkarna Celje d.d. Celje (CICG):企業の財務・戦略的SWOT分析
    Cinkarna Celje d.d. Celje (CICG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Sound Energy Plc (SOU):石油・ガス:M&Aディール及び事業提携情報
    Summary Sound Energy Plc (Sound Energy), formerly Sound Oil plc is an upstream oil and gas company that offers exploration and development of oil and gas properties in Europe and Africa. The company holds interests, owns, and operates the Badile permit located in the Piedmont Lombard Basin in northe …
  • Velatia SL:企業の戦略的SWOT分析
    Velatia SL - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • ISA Pharmaceuticals BV:製薬・医療:M&Aディール及び事業提携情報
    Summary ISA Pharmaceuticals BV (ISA Pharmaceuticals) is a developer of synthetic therapeutic vaccines for the treatment of cancer and persistent viral infections. The company’s pipeline products include ISA101, an immunotherapeutic vaccine for cervical cancer; MyISA, a personalized immunotherapy bas …
  • Baltimore Gas and Electric Co:企業の発電所・SWOT分析2018
    Baltimore Gas and Electric Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Dole Food Company Inc:企業のM&A・事業提携・投資動向
    Dole Food Company Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dole Food Company Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Navidea Biopharmaceuticals Inc (NAVB)-医療機器分野:企業M&A・提携分析
    Summary Navidea Biopharmaceuticals Inc (Navidea) is a precision medicine company that focuses on the development and commercialization of radiopharmaceutical agents and precision diagnostics. Its key product, Lymphoseek (technetium Tc 99m tilmanocept) injection, is a radiopharmaceutical agent used i …
  • Axalta Coating Systems Ltd.:戦略・SWOT・企業財務分析
    Axalta Coating Systems Ltd. - Strategy, SWOT and Corporate Finance Report Summary Axalta Coating Systems Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Rocky Mountain Chocolate Factory, Inc.:企業の戦略・SWOT・財務情報
    Rocky Mountain Chocolate Factory, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rocky Mountain Chocolate Factory, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Integra LifeSciences Holdings Corp (IART):企業の財務・戦略的SWOT分析
    Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • UPL Ltd (UPL):企業の財務・戦略的SWOT分析
    UPL Ltd (UPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Abdullah Al-Othaim Markets Co.:企業の戦略・SWOT・財務情報
    Abdullah Al-Othaim Markets Co. - Strategy, SWOT and Corporate Finance Report Summary Abdullah Al-Othaim Markets Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Bush Industries Inc
    Bush Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Bush Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CharlestonPharma LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary CharlestonPharma LLC (CharlestonPharma) is a drug development company that develops anti-nucleolin antibodies for the treatment of cancer. The company uses in vitro, ex vivo and in vivo proof of concept for its first-in-class fully human monoclonal antibodies that targets nucleolin located i …
  • Novartis Pharmaceuticals Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Novartis Pharmaceuticals Corp (Novartis), a subsidiary of Novartis AG, is a manufacturer of prescription drugs. The company portfolio includes cardio metabolic, ophthalmology, respiratory, neuroscience, immunology and dermatology, oncology, call and gene therapy. It provides medicines such a …
  • McPherson’s Ltd (MCP):企業の財務・戦略的SWOT分析
    McPherson's Ltd (MCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • KBL European Private Bankers S.A.:企業の戦略・SWOT・財務情報
    KBL European Private Bankers S.A. - Strategy, SWOT and Corporate Finance Report Summary KBL European Private Bankers S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆